Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2009 1
2011 1
2013 1
2016 2
2017 1
2018 5
2019 5
2020 3
2021 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
Galardi F, Luca F, Romagnoli D, Biagioni C, Moretti E, Biganzoli L, Leo AD, Migliaccio I, Malorni L, Benelli M. Galardi F, et al. Among authors: biagioni c. Biomolecules. 2020 Dec 15;10(12):1677. doi: 10.3390/biom10121677. Biomolecules. 2020. PMID: 33334040 Free PMC article. Review.
Charting differentially methylated regions in cancer with Rocker-meth.
Benelli M, Franceschini GM, Magi A, Romagnoli D, Biagioni C, Migliaccio I, Malorni L, Demichelis F. Benelli M, et al. Among authors: biagioni c. Commun Biol. 2021 Nov 2;4(1):1249. doi: 10.1038/s42003-021-02761-3. Commun Biol. 2021. PMID: 34728774 Free PMC article.
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
Migliaccio I, Romagnoli D, Galardi F, De Luca F, Biagioni C, Curigliano G, Criscitiello C, Minisini AM, Moretti E, Risi E, Guarducci C, Nardone A, Biganzoli L, Benelli M, Malorni L. Migliaccio I, et al. Among authors: biagioni c. JCO Precis Oncol. 2024 Feb;8:e2300285. doi: 10.1200/PO.23.00285. JCO Precis Oncol. 2024. PMID: 38427931 Clinical Trial.
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.
Risi E, Lisanti C, Vignoli A, Biagioni C, Paderi A, Cappadona S, Monte FD, Moretti E, Sanna G, Livraghi L, Malorni L, Benelli M, Puglisi F, Luchinat C, Tenori L, Biganzoli L. Risi E, et al. Among authors: biagioni c. Transl Oncol. 2023 Jan;27:101585. doi: 10.1016/j.tranon.2022.101585. Epub 2022 Nov 17. Transl Oncol. 2023. PMID: 36403505 Free PMC article.
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Galardi F, De Luca F, Biagioni C, Migliaccio I, Curigliano G, Minisini AM, Bonechi M, Moretti E, Risi E, McCartney A, Benelli M, Romagnoli D, Cappadona S, Gabellini S, Guarducci C, Conti V, Biganzoli L, Di Leo A, Malorni L. Galardi F, et al. Among authors: biagioni c. Breast Cancer Res. 2021 Mar 24;23(1):38. doi: 10.1186/s13058-021-01415-w. Breast Cancer Res. 2021. PMID: 33761970 Free PMC article. Clinical Trial.
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Rossi L, Biagioni C, McCartney A, Migliaccio I, Curigliano G, Sanna G, Moretti E, Minisini AM, Cinieri S, Tondini C, Arpino G, Bernardo A, Martignetti A, Risi E, Pestrin M, Boni L, Benelli M, Biganzoli L, Di Leo A, Malorni L. Rossi L, et al. Among authors: biagioni c. Breast Cancer Res. 2019 May 29;21(1):71. doi: 10.1186/s13058-019-1149-5. Breast Cancer Res. 2019. PMID: 31142370 Free PMC article.
29 results